Koura launches new HFA-152a early-stage development formulation facilities in the United Kingdom
This new service will aid early-stage development formulation using the low GWP medical propellant HFA-152a.
Boston, MA, USA May 14, 2021 – Koura is pleased to announce today the launch of a new HFA-152a pMDI formulation development and filling service utilising their dedicated facilities located on Thornton Science Park, Chester, UK.
This service is specifically intended to support clients with their early-stage development studies using HFA-152a, either those wishing to transition existing products, or who are seeking to formulate new molecules into a pMDI dosage form using the next generation low carbon footprint propellant.
A range of services with be made available, from bench scale compatibility studies up to 5L pilot scale manufacturing as well as raw material and finished product testing, method development, transfer and validation.
This new service will be supported by a highly skilled scientific and technical team with experience in delivering client projects.
A UK IMP licence application is expected in 2022 to facilitate manufacture of samples suitable for use in clinical trials.
The launch of this new service is part of a multi-year investment program to bring Zephex® 152a from the laboratory to the patient and follows an earlier announcement of a multimillion-pound sterling investment into a new cGMP Zephex® 152a medical propellant production facility.
Koura is a global leader in the development, manufacture and supply of fluorinated products that play a fundamental role in enhancing everyday lives. Koura is part of the Orbia community of businesses working together to advance life around the world. Koura’s products are used in a range of applications including the construction of towns and cities, keeping homes cool, food fresh and treating patients with respiratory conditions through providing medical propellants used in millions of the world’s pressurized metered-dose inhalers (pMDIs). Headquartered in Boston, Koura has commercial activities worldwide, with operations in the UK, Mexico, United States, Canada, India, and Japan.
Orbia is a community of businesses united by a shared purpose: to advance life around the world. The businesses that make up Orbia have a collective focus on ensuring food security, reducing water scarcity, reinventing the future of cities and homes, connecting communities to data infrastructure and expanding access to health and wellness with advanced materials. Orbia operates in the Precision Agriculture, Building and Infrastructure, Fluor, Polymer Solutions and Data Communications sectors. The company has commercial activities in more than 100 countries and operations in 44, with global headquarters in Mexico City, Boston, Amsterdam and Tel Aviv. For more information, please visit orbia.com